Stockscreener 앱 받기
7.65
1.06%
0.08
시간 외 거래:
7.65
전일 마감가:
$7.57
열려 있는:
$7.54
하루 거래량:
235.99K
Relative Volume:
0.80
시가총액:
$512.37M
수익:
$555.06M
순이익/손실:
$-39.48M
주가수익비율:
-12.75
EPS:
-0.6
순현금흐름:
$29.05M
1주 성능:
+2.68%
1개월 성능:
+7.90%
6개월 성능:
+8.97%
1년 성능:
-22.18%
1일 변동 폭
$7.47
$7.78
1주일 범위
$7.14
$7.78
52주 변동 폭
$5.81
$11.25
Bioventus Inc Stock (BVS) Company Profile
명칭
Bioventus Inc
전화
(919) 474-6700
주소
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
7.65 | 507.01M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-12-07 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2022-11-22 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2022-11-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 개시 | Craig Hallum | Buy |
| 2021-11-15 | 재개 | Morgan Stanley | Overweight |
| 2021-11-10 | 재개 | JP Morgan | Overweight |
| 2021-07-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-08 | 개시 | Canaccord Genuity | Buy |
| 2021-03-08 | 개시 | Goldman | Buy |
| 2021-03-08 | 개시 | JP Morgan | Overweight |
| 2021-03-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioventus Inc 주식(BVS)의 최신 뉴스
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
(BVS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - MSN
Will Bioventus Inc stock deliver consistent dividends2025 Earnings Impact & Growth Focused Investment Plans - moha.gov.vn
Bioventus (NYSE:BVS) Trading Down 1.1%Time to Sell? - MarketBeat
Why (BVS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Aug Analyst Calls: Why Bioventus Inc stock could outperform in 2025Gap Up & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Will Bioventus Inc. stock deliver consistent dividends2025 Market Outlook & Verified High Yield Trade Plans - Bölüm Sonu Canavarı
Why Bioventus Inc. stock is favored by top institutionsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Улправда
What Wall Street predicts for Bioventus Inc. stock priceJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - Улправда
Will Bioventus Inc. stock benefit from automationJuly 2025 Institutional & Reliable Price Breakout Alerts - DonanımHaber
Will Bioventus Inc. stock rally after Fed decisionsJuly 2025 Opening Moves & Target Return Focused Stock Picks - Улправда
Is Bioventus Inc. stock resilient to inflation2025 Market WrapUp & Community Consensus Picks - Улправда
BVS (Bioventus) Purchase Of Investment : $0.0 Mil (TTM As of Sep. 2025) - GuruFocus
Bioventus (BVS) Receives a Buy from Canaccord Genuity - The Globe and Mail
Bioventus Earnings Notes - Trefis
(BVS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bioventus Reports Strong Q3 2025 Financial Performance - MSN
Bioventus (NYSE:BVS) Director Sells $75,700.00 in Stock - MarketBeat
Bioventus Director Guy P Nohra Sells 10,000 Shares - TradingView — Track All Markets
Dir Nohra Sells 10,000 ($75.7K) Of Bioventus Inc [BVS] - TradingView — Track All Markets
Divisadero Street Capital Management LP Decreases Stock Position in Bioventus Inc. $BVS - MarketBeat
Geode Capital Management LLC Has $6.98 Million Stake in Bioventus Inc. $BVS - Defense World
American Century Companies Inc. Grows Stock Holdings in Bioventus Inc. $BVS - Defense World
Buy Signal: Why Bioventus Inc stock is favored by top institutionsQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - moha.gov.vn
HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Bioventus Inc. (BVS) Presents at Piper Sandler 37th Annual Healthcare ConferenceSlideshow - Seeking Alpha
Dir Nohra Files To Sell 10,000 Of Bioventus Inc [BVS] - TradingView
Is It Too Late To Consider Buying Bioventus Inc. (NASDAQ:BVS)? - Yahoo Finance
Will Bioventus Inc. stock reach Wall Street targetsTrade Exit Summary & Real-Time Market Sentiment Reports - Newser
Will Bioventus Inc. stock see insider buyingWeekly Stock Report & Short-Term High Return Ideas - Newser
(BVS) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Bioventus: A New Start (NASDAQ:BVS) - Seeking Alpha
How Bioventus Inc. stock performs in weak economy2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Bioventus (NASDAQ:BVS) Seems To Use Debt Quite Sensibly - 富途牛牛
Bioventus (NYSE:BVS) Trading Down 3.9%Here's What Happened - MarketBeat
Bioventus, Inc. Reports Strong Q3 Earnings Growth - MSN
Segall Bryant & Hamill LLC Purchases 232,302 Shares of Bioventus Inc. $BVS - MarketBeat
[Form 3] Bioventus Inc. Initial Statement of Beneficial Ownership - Stock Titan
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Bioventus (Nasdaq: BVS) to present at Piper Sandler 37th Healthcare Conference webcast - Stock Titan
Bioventus (NYSE:BVS) Shares Up 9.9%Time to Buy? - MarketBeat
Bioventus Appoints Ajay Dhankhar as New Director - MSN
Is Bioventus Inc. stock affected by interest rate hikesRisk Management & Weekly Chart Analysis and Guides - newser.com
Why Bioventus Inc. stock appeals to analystsJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
Is Bioventus Inc. stock attractive for income investorsMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
Bioventus Inc. stock prediction for this weekDollar Strength & High Conviction Investment Ideas - newser.com
Bioventus Inc (BVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):